Shanghai Creation Investment (SCI) Management Co.

www.scivc.com/en

Foreign Venture Capital Fund

Ceased to Operate Q4/2021

Tech Verticals Preferences

Automation, Big Data, Consumer Goods, DevOps, EDA, Energy Tech, Enterprise Applications, Industrial Technologies, Manufacturing & Equipment, Materials, Medical, Medical Devices, MedTech, Memory & Storage, Testing

General Data

Current Active Portfolio Companies:

DESCRIPTION

Shanghai Creation Investment Management (SCI) in Shanghai, China is one of the most active investment funds and IPO consulting companies in China. SCI successfully made investment in medical domains and other sectors. SCI provided well recognized consulting services for enterprises at different stage and under difference scenarios.

CONTACT INFO

Expand / Collapse All

Main Address: Shanghai, China

Address	777 West YanAn Rd., Room1904, YuFeng International Building
City	Shanghai
Country	China

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Investment Data

Managed Capital

abCDe

Capital Remarks

SCI currently manages three funds: SCI Domestic Technology Fund I (Fund Size: $60m); Domain: Advanced manufacturing, medical, consumer goods; Started: Oct 2010 SCI Advanced Technology Venture Capital Fund II (Fund size: $75m); Domains: Advanced manufacturing, medical, new material; Started: Oct 2014; Typical investment: $0.5m to $3m SCI Advanced Technology Fund of Funds (Fund Size: $30m); Started: July 2015 SCI is launching a new round of funds, including the International Master Fund, international venture capital funds and domestic venture capital funds.

Preferences

Maximum investments	$3m
Minimum investments	$0.5m
Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed
Phase Preferences	CE Approved,Clinical Trials,Discovery,FDA Approved,Phase I,Phase II,Phase III,Pre Clinical

SECTOR SEGMENTATION (By Number Of Companies)

Medical Devices

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

eHV

eHealth Ventures (eHV) is a multinational consortium conceived to provide “smart money” to promising early-stage digital health technology companies in Israel. eHealth's mission is developing innovative technological ideas into start-ups, and leading them towards first round Investment by providing the environment, initial funding, mentoring, and additional start up infrastructure and resources resulting in companies that have products and services to lower cost and/or improve healthcare outcomes. Participants receive funding both from eHealth Ventures and the Israel Innovation Authority (formerly the OCS). The incubator invests in a wide range of sectors within digital health. Fields include Lifestyle & wellness, mHealth, Home Care, Healthcare IT, Monitoring devices, I.o.T, Tele-health, Big Data, Image Processing and more. The strategic focus is on Digital Diagnostics and Digital Therapeutics.

N/A

Investment in Fund

15/03/2016

N/A

$12m

Surgical Theater

Second Round	30/09/2016	N/A	N/A
First Round	19/10/2015	N/A	$9m

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	04/01/2022	abCDe
abC Defghij	Acquired	01/06/2020	abCDe

Historic Portfolio (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Biop Medical

Ceased to Operate

First Round - Extended	19/01/2020	N/A	N/A
First Round - Extended	13/09/2018	N/A	$2.2m
First Round	01/12/2015	N/A	$2.25m

HIL Applied Medical

Ceased to Operate

Third Round

01/08/2016

N/A

$5m

Last Updated:	abCDe
IVC Number:	abCDe